Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines

Vaccine. 2003 Jul 4;21(23):3342-50. doi: 10.1016/s0264-410x(02)00804-6.

Abstract

The immunogenicity and protective capability of several baculovirus-expressed infectious bursal disease virus (IBDV)-derived assemblies as VP2 capsids, VPX tubules and polyprotein (PP)-derived mixed structures, were tested. Four-week-old chickens were immunised subcutaneously with one dose of each particulate antigen. VP2 icosahedral capsids induced the highest neutralising response, followed by PP-derived structures and then VPX tubules. All vaccinated animals were protected when challenged with a very virulent IBDV (vvIBDV) isolate, however the degree of protection is directly correlated with the levels of neutralising antibodies. VP2 capsids elicited stronger protective immunity than tubular structures and 3 micrograms of them were sufficient to confer a total protection comparable to that induced by an inactivated vaccine. Therefore, VP2 capsids represent a suitable candidate recombinant vaccine instead of virus-like particles (VLPs) for IBDV infections. Our results also provide clear evidence that the recombinant IBDV-derived antigens are structure-dependent in order to be efficient as vaccine components.

Publication types

  • Duplicate Publication
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Birnaviridae Infections / immunology
  • Birnaviridae Infections / prevention & control
  • Capsid / immunology
  • Cells, Cultured
  • Chickens / immunology*
  • Dose-Response Relationship, Immunologic
  • Immunization
  • Infectious bursal disease virus / chemistry
  • Infectious bursal disease virus / immunology*
  • Quality Control
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spodoptera
  • Structure-Activity Relationship
  • Vaccines, Synthetic / chemistry
  • Vaccines, Synthetic / immunology
  • Viral Proteins / biosynthesis
  • Viral Vaccines / chemistry
  • Viral Vaccines / immunology*

Substances

  • Vaccines, Synthetic
  • Viral Proteins
  • Viral Vaccines